BCAX
Price
$27.02
Change
-$0.71 (-2.56%)
Updated
Jul 24 closing price
Capitalization
1.78B
24 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$103.87
Change
-$0.92 (-0.88%)
Updated
Jul 24 closing price
Capitalization
5.68B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs DNTH

BCAX vs DNTH Comparison Chart in %
View a ticker or compare two or three
VS
BCAX vs. DNTH commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and DNTH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (BCAX: $27.73 vs. DNTH: $104.79)
Brand notoriety: BCAX and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 31% vs. DNTH: 38%
Market capitalization -- BCAX: $1.78B vs. DNTH: $5.68B
BCAX [@Biotechnology] is valued at $1.78B. DNTH’s [@Biotechnology] market capitalization is $5.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, BCAX is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 5 TA indicator(s) are bullish while DNTH’s TA Score has 6 bullish TA indicator(s).

  • BCAX’s TA Score: 5 bullish, 5 bearish.
  • DNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а +0.47% price change this week, while DNTH (@Biotechnology) price change was +9.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.69%. For the same industry, the average monthly price growth was -3.66%, and the average quarterly price growth was +1910.60%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

DNTH is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-4.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($5.68B) has a higher market cap than BCAX($1.78B). BCAX has higher P/E ratio than DNTH: BCAX (3.41) vs DNTH (3.24). DNTH YTD gains are higher at: 154.283 vs. BCAX (64.765). BCAX has higher annual earnings (EBITDA): -173.93M vs. DNTH (-190.92M). DNTH has more cash in the bank: 1.11B vs. BCAX (540M). DNTH has less debt than BCAX: DNTH (1.36M) vs BCAX (1.44M). DNTH has higher revenues than BCAX: DNTH (1.34M) vs BCAX (0).
BCAXDNTHBCAX / DNTH
Capitalization1.78B5.68B31%
EBITDA-173.93M-190.92M91%
Gain YTD64.765154.28342%
P/E Ratio3.413.24105%
Revenue01.34M-
Total Cash540M1.11B49%
Total Debt1.44M1.36M106%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
3
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXDNTH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 29 days ago
82%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BRKW38.430.05
+0.14%
Roundhill BRKB WeeklyPay ETF
FIVY24.55N/A
N/A
YieldMax Dorsey Wright Hybrid 5 Income ETF
EVLN48.66-0.07
-0.14%
Eaton Vance Floating-Rate ETF
EMBD23.57-0.11
-0.49%
Global X Emerging Markets Bond ETF
CCEF29.41-0.29
-0.97%
Calamos CEF Income & Arbitrage ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-0.82%
CLDX - BCAX
49%
Loosely correlated
+1.87%
PCVX - BCAX
47%
Loosely correlated
-0.64%
BCYC - BCAX
45%
Loosely correlated
-1.19%
NRIX - BCAX
44%
Loosely correlated
+0.59%
ORKA - BCAX
44%
Loosely correlated
-0.63%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+1.98%
XENE - DNTH
43%
Loosely correlated
-1.15%
EDIT - DNTH
42%
Loosely correlated
-1.80%
REPL - DNTH
41%
Loosely correlated
-2.70%
ROIV - DNTH
39%
Loosely correlated
+0.54%
BCAX - DNTH
38%
Loosely correlated
-0.82%
More